Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Việt Nam's 30 years in ASEAN: Common aspiration to build a region of peace, stability, and development 2.